Sinclair D, Smith A, Cranfield T, Lock R J
Department of Clinical Biochemistry, Queen Alexandra Hospital, Portsmouth, PO6 3LY, UK.
J Clin Pathol. 2004 Apr;57(4):445-7. doi: 10.1136/jcp.2003.013524.
Acquired C1 esterase inhibitor deficiency is a rare condition, usually presenting after the 2nd decade of life, and is often related to underlying conditions such as autoimmune and lymphoproliferative disorders. This case report describes a man whose initial clinical presentation with acute angioedema and whose initial estimation of a low C1 esterase inhibitor concentration indicated that he had an acquired angioedema, possibly secondary to a B cell neoplasm. A paraprotein was detected, and although its detection was serendipitous because it hinged on a spurious C1 esterase inhibitor result, this case confirms the role of C4 concentrations in the investigation of C1 esterase inhibitor deficiency. It also confirms the need to obtain repeat confirmatory samples before arriving at a diagnosis, however convincing the clinical signs may be.
获得性C1酯酶抑制剂缺乏是一种罕见疾病,通常在20岁以后出现,且常与自身免疫性疾病和淋巴增殖性疾病等潜在疾病相关。本病例报告描述了一名男性,其最初表现为急性血管性水肿,且最初检测的C1酯酶抑制剂浓度较低,提示他患有获得性血管性水肿,可能继发于B细胞肿瘤。检测到了一种副蛋白,尽管其检测是偶然的,因为它依赖于一个虚假的C1酯酶抑制剂结果,但该病例证实了C4浓度在C1酯酶抑制剂缺乏症调查中的作用。它还证实了在做出诊断之前需要获取重复的确认样本,无论临床症状多么令人信服。